Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening

Pharmacology, Toxicology and Pharmaceutical Science

• Atherosclerosis 14%
• Dimethylargininase 100%
• Fibrosing Alveolitis 14%
• Headache 14%
• Hypertension 14%
• Inducible Nitric Oxide Synthase 14%
• Insulin Resistance 14%
• Malignant Neoplasm 14%
• Metabolic Disorder 14%
• Migraine 14%
• N(g),n(g) Dimethylarginine 42%
• Nitric Oxide 71%
• Nitric Oxide Synthase 28%
• Sepsis 14%
• Vascular Disease 14%

Biochemistry, Genetics and Molecular Biology

• Chemical Screening 28%
• Contrast 14%
• Development 14%
• Electric Potential 14%
• Homeostasis 14%
• Insulin Resistance 14%
• Molecule 14%
• Nitric Oxide 71%
• Nitric Oxide Synthase 42%
• Oxidative Stress 14%
• Regulatory Mechanism 14%
• Small Molecule 42%